Loomis Sayles & Co. L P decreased its position in Healthequity Inc (NASDAQ:HQY) by 8.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 556,385 shares of the company’s stock after selling 52,620 shares during the period. Loomis Sayles & Co. L P’s holdings in Healthequity were worth $52,529,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. increased its stake in Healthequity by 11.3% in the second quarter. BlackRock Inc. now owns 7,688,768 shares of the company’s stock valued at $577,427,000 after purchasing an additional 777,915 shares in the last quarter. FMR LLC increased its stake in Healthequity by 26.5% in the second quarter. FMR LLC now owns 3,410,542 shares of the company’s stock valued at $256,132,000 after purchasing an additional 715,441 shares in the last quarter. Carillon Tower Advisers Inc. increased its stake in Healthequity by 751.9% in the second quarter. Carillon Tower Advisers Inc. now owns 752,482 shares of the company’s stock valued at $56,511,000 after purchasing an additional 664,157 shares in the last quarter. United Services Automobile Association increased its stake in Healthequity by 3,569.2% in the second quarter. United Services Automobile Association now owns 284,360 shares of the company’s stock valued at $4,558,000 after purchasing an additional 276,610 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. bought a new stake in Healthequity in the third quarter valued at $19,021,000. Institutional investors and hedge funds own 93.01% of the company’s stock.
In other news, VP Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction dated Tuesday, November 20th. The shares were sold at an average price of $76.91, for a total transaction of $307,640.00. Following the completion of the sale, the vice president now directly owns 89,500 shares of the company’s stock, valued at $6,883,445. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Over the last three months, insiders have sold 12,000 shares of company stock valued at $1,027,400. 4.00% of the stock is currently owned by insiders.
Healthequity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 4th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.22 by $0.12. The company had revenue of $71.10 million during the quarter, compared to the consensus estimate of $69.84 million. Healthequity had a net margin of 23.81% and a return on equity of 12.58%. The firm’s revenue for the quarter was up 25.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.27 earnings per share. On average, research analysts anticipate that Healthequity Inc will post 0.87 EPS for the current year.
Several equities research analysts have weighed in on HQY shares. Raymond James lifted their price target on shares of Healthequity from $85.00 to $105.00 and gave the company an “outperform” rating in a research note on Monday, September 10th. Bank of America downgraded shares of Healthequity from a “buy” rating to a “neutral” rating and lifted their price target for the company from $84.00 to $105.00 in a research note on Thursday, September 6th. They noted that the move was a valuation call. SunTrust Banks lifted their price target on shares of Healthequity to $105.00 and gave the company a “buy” rating in a research note on Wednesday, September 5th. BidaskClub raised shares of Healthequity from a “buy” rating to a “strong-buy” rating in a research note on Thursday, November 1st. Finally, Cantor Fitzgerald boosted their target price on shares of Healthequity from $68.00 to $80.00 and gave the stock a “neutral” rating in a research report on Wednesday, September 5th. Four equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $93.08.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More: What is systematic risk?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.